AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12409326
Drug: Gemcitabine 1,250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1,250 mg/m(2) days 1 and 8 plus cisplatin 75 mg/m(2) day 2 every 21 days (GC arm)
Trial: 12409326
Drug: Paclitaxel 225
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 225 mg/m(2) (3‐hour infusion) then carboplatin (AUC 6 mg/mL x min) on day 1 every 21 days (PCb arm)
Trial: 12409326
Drug: Vinorelbine 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinorelbine 25 mg/m(2)/wk for 12 weeks then every other week plus cisplatin 100 mg/m(2) day 1 every 28 days (VC arm)
Trial: 10334422
Drug: Oral coenzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral coenzyme Q for 3 months
Trial: 30159300
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group - COPD conventional medications and walking on paved surfaces
Trial: 20143247
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of pure oxygen
Trial: 20143247
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of air (placebo)
Trial: 17936285
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist administration (early studies)
Trial: 17936285
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist administration (later studies)
Trial: 21820233
Drug: Postoperative administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative administration of oral pregabalin 75 mg
Trial: 14609895
Drug: 30% sucrose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30% sucrose intraoral administration
Trial: 10674411
Drug: No drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drugs (Control)
Trial: 9172968
Drug: Maprotiline (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline (75 mg/day)
Trial: 25670636
Drug: No statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No statin treatment (control group)
Trial: 8047827
Drug: Ranitidine, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 150 mg twice daily
Trial: 4089577
Drug: Highly purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly purified duck embryo rabies vaccine (PDEV)
Trial: 28318872
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg dexamethasone injection into the pterygomandibular space
Trial: 26216071
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose gefitinib (500 mg/d; H group)
Trial: 26216071
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose gefitinib (250 mg/d; S group)
Trial: 23336248
Drug: Opicapone 5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opicapone 5, 10, 20 or 30 mg
Trial: 16987384
Drug: Quinidine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine plus verapamil (Q+V) 480/240 mg/day
Trial: 16987384
Drug: Quinidine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine plus verapamil (Q+V) 320/160 mg/day
Trial: 1705386
Drug: Sotalol 320
RxNorm normalized name: sotalol 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol 320 mg/day
Trial: 12767414
Drug: Ginkgo (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo (240 mg/d or 160 mg/d)
Trial: 11037003
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg/d)
Trial: 3120989
Drug: Fixed minidose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed minidose warfarin (1 mg daily for mean 20 days)
Trial: 3120989
Drug: Full dose
RxNorm normalized name: BayRHo-D Full Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full dose oral anticoagulation
Trial: 3120989
Drug: Fixed minidose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed minidose warfarin
Trial: 28500434
Drug: Individualized parent-child
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized parent-child treatment
Trial: 26599569
Drug: Intramuscular benzathine
RxNorm normalized name: Cephapirin Benzathine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular benzathine benzylpenicillin (BPG)
Trial: 23394910
Drug: Patients who
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients who declined the herpes zoster vaccine
Trial: 26285130
Drug: Neither medication
RxNorm normalized name: 2,2',3,3',4,4',5,5',6-nonachlorodiphenyl either
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neither medication
Trial: 14662276
Drug: Run-in period
RxNorm normalized name: Run Guard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Run-in period prior to randomized treatment-group assignment
Trial: 9106558
Drug: Medroxyprogesterone, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone, 10 mg
Trial: 24739290
Drug: No stretching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No stretching treatment
Trial: 19717846
Drug: Clopidogrel (300-to-600-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300-to-600-mg loading dose, 75 mg daily thereafter)
Trial: 12658810
Drug: Clavulanate Potassium
RxNorm normalized name: Clavulanate Potassium
DrugBank: Clavulanic acid (DB00766)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clavulanate Potassium and Amoxicillin (1:7) dispersible tablets (Tested formulation, T)
Trial: 31654294
Drug: Elagolix 150
RxNorm normalized name: elagolix 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elagolix 150 mg QD
Trial: 31650182
Drug: Elagolix 200
RxNorm normalized name: elagolix 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elagolix 200 mg QD
Trial: 31650182
Drug: Elagolix 300
RxNorm normalized name: elagolix 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elagolix 300 mg BID
Trial: 30834932
Drug: Behavioural e‐learning
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioural e‐learning intervention to support nurses in managing interruptions during medication administration
Trial: 19745565
Drug: Clinical dose
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical dose of nicardipine (20 mg)
Trial: 1794430
Drug: Tropicamide 1%
RxNorm normalized name: TROPICAMIDE 1% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropicamide 1% in combination with phenylephrine 10%
Trial: 6403956
Drug: Co-dergocrine mesylate
RxNorm normalized name: co-dergocrine mesylate
DrugBank: Ergoloid mesylate (DB01049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-dergocrine mesylate 4.5 mg once daily
Trial: 22512698
Drug: Intestine without
RxNorm normalized name: pork intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intestine without olive leaf treatment
Trial: 16013899
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR 150 mg daily
Trial: 26976426
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg once per day
Trial: 26976426
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg with pictilisib 260 mg once per day
Trial: 21926153
Drug: treatment to
RxNorm normalized name: Lice Treatment Topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment to target (TT)
Trial: 21926153
Drug: treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment as needed (PRN)
Trial: 17111793
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (combination of topical and systemic antibiotics)
Trial: 17111793
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (topical antimicrobials alone)
Trial: 10814631
Drug: Cocaine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (2 mg/kg intranasally)
Trial: 9121824
Drug: Treatment Helpfulness
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment Helpfulness Questionnaire (THQ)
Trial: 1797464
Drug: Norinyl 1+35
RxNorm normalized name: Norinyl 1+35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norinyl 1+35 (35 mcg ethinyl estradiol)
Trial: 1797464
Drug: Norinyl 1+50
RxNorm normalized name: Norinyl 1+50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norinyl 1+50 (50 mcg mestranol)
Trial: 29378662
Drug: ART refills
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ART refills supplied 6-monthly within CARGs
Trial: 29378662
Drug: ART refills
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ART refills supplied 3-monthly from the health facility (control arm)
Trial: 29378662
Drug: ART refills
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ART refills supplied 3-monthly within CARGs
Trial: 17659159
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg/day added to ongoing statin therapy
Trial: 12423708
Drug: Placebo added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo added to ongoing statin therapy
Trial: 27671007
Drug: Postnatal additional
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postnatal additional high-dose oral vitamin A supplementation for 28 days (exact dosage not specified)
Trial: 11081892
Drug: ANP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ANP treatment (0.05 microg x kg(‐1) x min(‐1) for 6 hours)
Trial: 11081892
Drug: No ANP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ANP treatment (control group)
Trial: 3159163
Drug: muzolimine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: muzolimine (20 mg once daily for three weeks)
Trial: 3159163
Drug: nitrendipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nitrendipine (10 mg twice daily for four weeks)
Trial: 22396514
Drug: Continued AED
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued AED treatment (n = 23)
Trial: 20498393
Drug: FU-based therapy
RxNorm normalized name: fu ling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FU-based therapy (either FU + levamisole or FU + leucovorin)
Trial: 20498393
Drug: FU-based therapy
RxNorm normalized name: fu ling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FU-based therapy (in pooled data set)
Trial: 11228380
Drug: QS‐21 formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QS‐21 formulations
Trial: 9052304
Drug: Lidocaine 1.5%
RxNorm normalized name: LIDOCAINE 1.5%/EPI 1:200000 INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1.5% (10 mL)
Trial: 29405668
Drug: Saline (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (10 mL)
Trial: 9052304
Drug: Control sham
RxNorm normalized name: Dandruff Control Shampoo Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control sham (0.5 mL saline)
Trial: 8300895
Drug: Sublingual estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual estradiol hydroxypropyl‐beta‐cyclodextrin (estradiol‐HP beta CD) 0.675 mg
Trial: 8300895
Drug: Oral micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral micronized estradiol 1 mg
Trial: 8300895
Drug: Sublingual estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual estradiol hydroxypropyl‐beta‐cyclodextrin (estradiol‐HP beta CD)
Trial: 8300895
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol hydroxypropyl‐beta‐cyclodextrin
Trial: 12057715
Drug: Oral micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral micronized estradiol
Trial: 8300895
Drug: Both oral
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both oral doses (estradiol-HP beta CD and micronized estradiol)
Trial: 27558901
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release oxycodone plus naloxone up to 20 mg per day
Trial: 18588370
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment plus intravenous infusions of cyclophosphamide 15 mg/kg daily for two days, methylprednisolone one gram daily for three days, and mesna 15 mg/kg for four days.
Trial: 10634839
Drug: Thiopental 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 6 mg/kg
Trial: 11447952
Drug: 8 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg/kg ketamine + 0.1 mg/kg diazepam
Trial: 30481374
Drug: 3.75 mg/mL
RxNorm normalized name: threonine 3.75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg/mL ropivacaine infiltration followed by 2 mg/mL ropivacaine continuous wound infiltration (CWI) for 96 hours
Trial: 30481374
Drug: 3.75 mg/mL
RxNorm normalized name: threonine 3.75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg/mL ropivacaine infiltration followed by 2 mg/mL ropivacaine CWI
Trial: 21848574
Drug: prucalopride 2
RxNorm normalized name: prucalopride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prucalopride 2 mg once daily
Trial: 21848574
Drug: prucalopride 10
RxNorm normalized name: PRUCALOPRIDE
DrugBank: Prucalopride (DB06480)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: prucalopride 10 mg once daily
Trial: 21848574
Drug: placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo with 400 mg moxifloxacin on day 1
Trial: 11903856
Drug: Slow-release caffeine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release caffeine (SRC) 300 mg given twice daily (21:00 and 9:00 h) during SD
Trial: 24090176
Drug: Other drug
RxNorm normalized name: Other drugs for bile therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other drug risk, family risk, and having an abnormal liver enzyme test result
Trial: 19945857
Drug: PTK787/ZK222584 (PTK/ZK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTK787/ZK222584 (PTK/ZK) at a dose of 1000 mg once daily in combination with radiotherapy and temozolomide (TMZ)
Trial: 19945857
Drug: PTK787/ZK222584 (PTK/ZK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTK787/ZK222584 (PTK/ZK) at a dose of 1250 mg once daily
Trial: 14626338
Drug: Fluticasone propionate/salmeterol
RxNorm normalized name: fluticasone propionate/salmeterol 100/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone propionate/salmeterol combination (FSC) 100/50 or 250/50 microg twice daily
Trial: 28418966
Drug: Methadone 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone 0.2 mg/kg at the start of surgery
Trial: 26018333
Drug: Estradiol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol (100 µg/d)
Trial: 11405325
Drug: Daily welding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily welding
Trial: 2884797
Drug: Vecuronium (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (20 micrograms/kg priming dose, 60 micrograms/kg intubating dose)
Trial: 2884797
Drug: Atracurium (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium (100 micrograms/kg priming dose, 300 micrograms/kg intubating dose)
Trial: 28770947
Drug: Anti-epileptic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-epileptic therapy with vitamin B12 (mecobalamin)
Trial: 28770947
Drug: Anti-epileptic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-epileptic therapy with compound vitamin B tablets
Trial: 23956857
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg of lignocaine hydrochloride
Trial: 23956857
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg of dexamethasone
Trial: 23956857
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of preservative-free saline
Trial: 15014300
Drug: Concomitant administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concomitant administration of Comvax, M‐M‐RII and Varivax
Trial: 9850204
Drug: Sertraline (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50, 100 or 200 mg)
Trial: 30649711
Drug: Metformin IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin IR crushed tablets
Trial: 28762527
Drug: Eliglustat (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eliglustat (9 months initial treatment, followed by 9 months in extension)
Trial: 23735473
Drug: Prasugrel 10
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10 mg OD
Trial: 21219403
Drug: Amoxicillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanic acid (amoxiclav)
Trial: 16798773
Drug: bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 0.25% 0.75 ml kg(‐1) with tramadol 2 mg kg(‐1) (Group BT2)
Trial: 16798773
Drug: bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 0.25% 0.75 ml kg(‐1) (Group B)
Trial: 16798773
Drug: bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 0.25% 0.75 ml kg(‐1) with tramadol 1 mg kg(‐1) (Group BT1)
Trial: 16798773
Drug: bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 0.25% 0.75 ml kg(‐1) with tramadol 1.5 mg kg(‐1) (Group BT1.5)
Trial: 11079528
Drug: Caffeine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (6 mg x kg(‐1) body mass)
Trial: 11079528
Drug: Caffeine (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (9 mg x kg(‐1) body mass)
Trial: 9354537
Drug: Low-dose sotalol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sotalol (80 mg twice daily)
Trial: 2246915
Drug: Low-dose sotalol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sotalol
Trial: 3759774
Drug: Resistive loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistive loading (33, 57, and 73 cm H2O X l‐1 X s) during exercise tests
Trial: 17715033
Drug: Periodic tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periodic tamoxifen treatment
Trial: 17715033
Drug: Consecutive tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Consecutive tamoxifen treatment
Trial: 8157768
Drug: Flurbiprofen (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen (100 mg daily)
Trial: 3046405
Drug: Extracts composed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extracts composed of any combination of alder, birch and hazel pollen (Group 1 (ABC))
Trial: 26591200
Drug: combined preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: combined preparation (fenoterol/ipratropium bromide)
Trial: 23747795
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) delivery of indocyanine green (ICG)
Trial: 21627558
Drug: Risedronate 35
RxNorm normalized name: risedronate 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 35 mg once a week and calcium with vitamin D
Trial: 20180356
Drug: Risedronate 35
RxNorm normalized name: risedronate 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 35 mg once a week
Trial: 12679710
Drug: Nutritional status
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional status improvement and treatment of parasitic infections
Trial: 8440759
Drug: Methylprednisolone (20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (20, 50, 80 mg)
Trial: 8440759
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (20, 50, 80 mg)
Trial: 8440759
Drug: Dexamethasone (20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (20, 50, 80 mg)
Trial: 4063010
Drug: Veterans Administration
RxNorm normalized name: benzalkonium chloride Topical Foam [Veteran Shield 24]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Veterans Administration nursing care units